Surrey Heartlands

Joint Formulary & PAD

Salbutamol (Easyhaler Salbutamol) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Salbutamol (Easyhaler Salbutamol) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Preferred

Documentation

Guidelines (Local)
In-Check device for improving inhaler technique - Nov 16
Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Webpage
How to use an Easyhaler inhaler - video
Patient resource
How to use an Easyhaler inhaler - Patient information leaflet

PAD Profile

ChemicalSubstance :
Salbutamol (Easyhaler Salbutamol)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
SABA
Keywords :
salbutamol inhalers, SABAs, bronchodilators, adrenoreceptor agonists, short acting beta 2 agonists, respiratory, reliever inhalers
Brand Names Include :
Easyhaler Salbutamol
Important Information :

Cost-effective, low carbon DPI.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
4

Other Indications

Below are listed other indications that Salbutamol (Easyhaler Salbutamol) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

02 Nov 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Salbutamol Easyhaler or Ventolin Accuhaler are the locally preferred, low carbon, dry powder devices

Alternative devices:

  • Salamol (MDI) is the locally preferred salbutamol metered dose inhaler device and should be used with a spacer device. It has a lower carbon footprint than the large volume MDIs such as Ventolin.
  • Ventolin Evohaler (MDI) 

Branded prescribing of inhaler devices is recommended.
See COPD guidelines below